(Q39865730)

15 September 2017

title

Azithromycin increases chloride efflux from cystic fibrosis airway epithelial cells (English)

1 reference

15 September 2017

0 references

0 references

Igor Oliynyk

1

1 reference

15 September 2017

Georgia Varelogianni

2

1 reference

15 September 2017

Martin Schalling

3

1 reference

15 September 2017

Monika Stenkvist Asplund

4

1 reference

15 September 2017

Godfried M Roomans

5

1 reference

15 September 2017

Marie Johannesson

6

1 reference

15 September 2017

publication date

1 April 2009

1 reference

Experimental Lung Research

15 September 2017

published in

1 reference

15 September 2017

volume

35

1 reference

15 September 2017

issue

3

1 reference

15 September 2017

page(s)

210-221

1 reference

Normal and cystic fibrosis airway surface liquid homeostasis. The effects of phasic shear stress and viral infections

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

Cystic Fibrosis: The Mechanisms of Pathogenesis of an Inherited Lung Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

Increased prevalence of chronic rhinosinusitis in carriers of a cystic fibrosis mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

The use of macrolide antibiotics in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

Azithromycin for cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

Immunomodulation by macrolide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

Novel effects of azithromycin on tight junction proteins in human airway epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

Accumulation of azithromycin and roxithromycin in tracheal epithelial fetal cell lines expressing wild type or mutated cystic fibrosis transmembrane conductance regulator protein (CFTR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

In Vivo Induction of Liver P-Glycoprotein Expression by Xenobiotics in Monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

Biochemical, cellular, and pharmacological aspects of the multidrug transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

An inventory of the human ABC proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

Effect of macrolides on in vivo ion transport across cystic fibrosis nasal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

Exploring the mechanisms of macrolides in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

Long-term azithromycin in cystic fibrosis: another possible mechanism of action?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

Measurement of halide efflux from cultured and primary airway epithelial cells using fluorescence indicators

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

A non-capacitative pathway activated by arachidonic acid is the major Ca2+ entry mechanism in rat A7r5 smooth muscle cells stimulated with low concentrations of vasopressin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

Molecular structure and physiological function of chloride channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

New insights into the pathogenesis of cystic fibrosis: pivotal role of glutathione system dysfunction and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

Interaction of the macrolide antibiotic azithromycin with lipid bilayers: effect on membrane organization, fluidity, and permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

Azithromycin exhibits bactericidal effects on Pseudomonas aeruginosa through interaction with the outer membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

Real-time imaging of drug-membrane interactions by atomic force microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

Pharmacologic therapy for stop mutations: how much CFTR activity is enough?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

Heterogeneity of treatment response to azithromycin in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

Improved lung function and body mass index associated with long-term use of Macrolide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

Effects of azithromycin on the expression of ATP binding cassette transporters in epithelial cells from the airways of cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

Azithromycin retards Pseudomonas aeruginosa biofilm formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

Long term effects of azithromycin in patients with cystic fibrosis: A double blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

Anti-inflammatory effects of macrolide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

Azithromycin reduces spontaneous and induced inflammation in DeltaF508 cystic fibrosis mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

Decrease of elastic moduli of DOPC bilayers induced by a macrolide antibiotic, azithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01902140802534967

10.1080/01902140802534967

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference